Kraig Biocraft Laboratories Prepares For Challenge Testing Of Disease Resistant Silkworm Lines  

ANN ARBOR, Mich. — September 28, 2021 — Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announced today that it is preparing to conduct challenge testing on two lines of immunity enhanced silkworms. These silkworm lines were developed by Kraig Labs to combat two of the biggest challenges facing the global silk production industry.

It has been reported that as much as 50 percent of all losses in silk production result from a single widespread virus. A 2020 paper cited that 75 percent of all interviewer silkworm raisers reported losses due to this disease. With no effective treatment, this virus results in countless millions of dollars of economic annually. Kraig Labs realized that technologies it was developing for other applications could be used to significantly reduce these losses in the broader silk industry. The company has made rapid progress in the development of this new technology.

Specifically designed to target and combat this virus and other pathogens, these new transgenics developed by Kraig Labs, are now preparing to undergo challenge testing. These new disease-resistant lines of silkworms are intended for licensing into the global market for mundane silks to combat pathogenic viruses and fungi. The company expects to make these lines of resilient silkworms available for commercial licensing shortly after the conclusion of successful challenge testing.

“We are very excited to begin challenge testing for these immunity enhanced silkworm lines,” said COO Jon Rice. “Our intention is to license this technology to silk produces all over the world. This program to produce licensable commercial lines of more robust silkworms is the perfect complement to our core focus, the commercialization of Kraig’s eco-friendly recombinant spider silk.”

1 From New Analysis from Global Industry Analysts Reveals Steady Growth for Silk, with the Market to Reach $21 Billion Worldwide by 2026, read more at:

Posted September 28, 2021

Source: Kraig Biocraft Laboratories